IBL-302 PIM/PI3K/mTOR triple kinase inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells

SRP202201

Homo sapiens

9 Downloadable Samples

Ion Torrent S5 XL

Submitter Supplied Information

Description

neuroblastoma cells derived from PDOX models were treated with the kinase inhibitor. Overall design: 5 repetitions of control and IBL-302 treated cells were harvest and submitted for RNAseq analysis

PubMed ID

31310053

Publication Title

Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Total Samples

Submitter’s Institution

No associated institution

Authors

Mohlin S, Hansson K, Radke K, Martinez S, Blanco-Apiricio C, Garcia-Ruiz C, Welinder C, Esfandyari J, O'Neill M, Pastor J, von Stedingk K, Bexell D

Source Repository

Sequence Read Archive (SRA)

No rows found